MARISA JENNINGS: Open Payments
NPI 1902067366 · MINOT, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 14 payments from 8 companies in 2025. Trend: 2023 $613 · 2024 $373 · 2025 $357
Food & beverage: $256Education: $101
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
| Lundbeck LLC | 2 | $38 |
| Neurocrine BioSciences, Inc. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Alkermes, Inc. | 1 | $17 |
Products named: TRINTELLIX, REXULTI, Jornay PM, INGREZZA, COBENFY, ARISTADA.
Industry payments across ND — which companies pay providers there.
